We exist to maximise the quality of life for people with blood disorders

Multiple Myeloma Clinical Trials Appeal

PBI is committed to developing new treatments for blood cancers and facilitates patient participation in clinical trials to access potentially lifesaving treatments not currently available elsewhere. Your support will enable us to participate in testing new treatment options to improve the health outcomes for patients with blood disorders, including multiple myeloma.

Published:

Author: Anita Lee

Target amount: $2,147,483,647.00

Amount raised: $35.60

Fundraise

Participate in a clinical trial

PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers. We regularly take part in new clinical trials for improved treatments for blood disorders – this provides Western Australians with the opportunity to access new treatments.

Published:

Author:

Participate in a research project

PBI regularly participates in clinical trials to support improved treatments for blood disorders, providing Western Australians with the opportunity to access new treatments.

Published:

Author:

Our Impact

424

Biobanked samples for translational resesarch.

24

Partnering haematology centres in the Asia-Pacific.    

1200

Clinical trial patient appointments.

19

Active clinical trials.

Make a donation

Please select a donation amount (required)
Set up a regular donationDonate

Latest news

Upcoming events

  • Another Bloody Breakfast

    Join us on May 21 at the University Club of WA to hear from our panel of speakers as we cover the topic of the importance of clinical trials. Read more